Ghassan Abou-Alfa, MD, MBA; Attending, Memorial Sloan Kettering Cancer Center; Professor, Weill Cornell College at Cornell University
Dr Abou-Alfa discusses his CIO2022 abstract, "Transarterial Chemoembolization ± (Tremelimumab and Durvalumab ± Lenvatinib) in Hepatocellular Carcinoma: EMERALD-3."
CLICK HERE TO READ THE FULL ABSTRACT AND VIEW POSTER
